Datasheet | April 29, 2021

A Truly Revolutionary Platform For Decentralized Clinical Trials

Source: Encapsia

Our industry is now, more than ever, ready to move to decentralized trials (DCT) and design hybrid protocols that support trial continuity and have a more patient-centric approach.

Through discussions with our clients, it’s clear that most sponsors have struggled to implement DCT and need an innovative, modern technology platform that enables more efficient and future-ready trial processes.

The unique architecture of encapsia brings the technology to the data and provides an agile, revolutionary way to support decentralized clinical trial.

As the industry accelerates the adoption of new technologies, now is the time you need a modern DCT platform: powerful, flexible and innovative. Take control of your clinical data and remove the barriers to trial continuity.

Step forward with encapsia and let us demonstrate how choosing the right technology can transform your trials of tomorrow.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader